H Plus Pharma specializes in distribution of biotechnology and pharmaceutical products and also medical products.
The company signed a number of long-term agreements with the large international pharmaceutical companies about distribution of products in the territory of Syria.
History
2018: Distribution of a pharmproduktion of Nativa
The pharmaceutical company "Nativa" in February, 2018 announced signing of a number of agreements with foreign distributors on deliveries of the Russian products to the countries of the Middle East and East Asia. Total amount of contracts exceeded $1.5 million.
Agreements were signed with such foreign players as the Mongolian distributor Monos Pharma Trade LLC, the Syrian company H Plus Pharma and the Lebanese company Integrated Pharma Solutions (IPS). Read more here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |